Meeting Banner
Abstract #1762

Longitudinal MR Microscopy at 7T of Human Derived Osteosarcoma Mouse Models an Early Assessment of Drug Response

Parastou Foroutan1, Jenny M. Kreahling2, Damon Reed2, 3, Mark C. Lloyd4, Soner Altiok2, 3, Gary V. Martinez1, Robert J. Gillies1

1Imaging, H. Lee Moffitt Cancer Center, Tampa, FL, United States; 2Experimental Therapeutics Program, H. Lee Moffitt Cancer Center, Tampa, FL, United States; 3The Sarcoma Program, H. Lee Moffitt Cancer Center, Tampa, FL, United States; 4Analytic Microscopy, H. Lee Moffitt Cancer Center, Tampa, FL, United States

MRI at 7T was employed to evaluate the therapeutic effects of MK1775 and gemcitabine (Gem) in patient derived xenograft mouse models for osteosarcoma. ROI analysis showed significantly smaller tumor volumes for the treated animals compared to controls, particularly the Gem and Combination (Comb) groups. Significant increases in mean ADC for these groups were observed immediately following the first treatment, which also correlated with changes in skewness and kurtosis. Histology also showed significantly higher apoptosis and DNA damage in Comb and while tumor volume correlated well with these insults, changes in ADC indicating treatment response occured at earlier time points.

Keywords

accordingly administration already alterations although amount analytic anesthetized animal animals apparent applying assessment axial bone cancer chemotherapy cleaved coefficients coil comb combination common constant continuously control controls cure currently curve daily damage days decade demonstrating demonstrative derived determined diagnosis diffusion disease displayed distribution doses drug drugs earlier early employed equivalent evaluate experimental fact fast female final findings formation functions gradients growth highest histological horizontal hours human immediately implanted importantly improved incidence induce instruments insults jenny kurtosis larger lesion life longitudinal magnet mainstay malignant mark metastatic mice microscopy minutes models modestly monitored mouse necrosis notably novel often overt particular particularly patient patients peak percent physiological placed plotted prior program quantification quantitative rather receiving recurrent reed remained removal resolution response returned sarcoma sarcomas serve significantly similarly slice smaller staining subcutaneously surgical system taken targeted technologies therapeutic therapeutics therapy thereby throughout tissue together treated treatment tumor tumors twice type verify visually volume volumes whereas